Adecatumumab: Difference between revisions

Jump to navigation Jump to search
m (Protected "Adecatumumab": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
 
Line 26: Line 26:
}}
}}
{{SI}}
{{SI}}
{{EH}}
 


==Overview==
==Overview==
Line 35: Line 35:


{{humanmonoclonals}}
{{humanmonoclonals}}
{{SIB}}
 
[[Category:Monoclonal antibodies]]
[[Category:Monoclonal antibodies]]
[[Category:Cancer treatments]]
[[Category:Cancer treatments]]

Latest revision as of 20:42, 8 August 2012

Template:Drugbox-mab

WikiDoc Resources for Adecatumumab

Articles

Most recent articles on Adecatumumab

Most cited articles on Adecatumumab

Review articles on Adecatumumab

Articles on Adecatumumab in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Adecatumumab

Images of Adecatumumab

Photos of Adecatumumab

Podcasts & MP3s on Adecatumumab

Videos on Adecatumumab

Evidence Based Medicine

Cochrane Collaboration on Adecatumumab

Bandolier on Adecatumumab

TRIP on Adecatumumab

Clinical Trials

Ongoing Trials on Adecatumumab at Clinical Trials.gov

Trial results on Adecatumumab

Clinical Trials on Adecatumumab at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Adecatumumab

NICE Guidance on Adecatumumab

NHS PRODIGY Guidance

FDA on Adecatumumab

CDC on Adecatumumab

Books

Books on Adecatumumab

News

Adecatumumab in the news

Be alerted to news on Adecatumumab

News trends on Adecatumumab

Commentary

Blogs on Adecatumumab

Definitions

Definitions of Adecatumumab

Patient Resources / Community

Patient resources on Adecatumumab

Discussion groups on Adecatumumab

Patient Handouts on Adecatumumab

Directions to Hospitals Treating Adecatumumab

Risk calculators and risk factors for Adecatumumab

Healthcare Provider Resources

Symptoms of Adecatumumab

Causes & Risk Factors for Adecatumumab

Diagnostic studies for Adecatumumab

Treatment of Adecatumumab

Continuing Medical Education (CME)

CME Programs on Adecatumumab

International

Adecatumumab en Espanol

Adecatumumab en Francais

Business

Adecatumumab in the Marketplace

Patents on Adecatumumab

Experimental / Informatics

List of terms related to Adecatumumab


Overview

Adecatumumab is a human monoclonal antibody which it's used to target tumor cells. It binds to the epithelial cell adhesion molecule (EpCAM).

External links

Template:Humanmonoclonals


Template:WS